Clinical Trials on Fallopian Tube Patency Tests in Italy
Total 45 results
-
Fondazione Policlinico Universitario Agostino Gemelli...Istituto Di Ricerche Farmacologiche Mario Negri; Foundation MedicineRecruitingAdvanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube CancerItaly
-
Hospices Civils de LyonUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Merck Sharp & Dohme LLCRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaActive, not recruitingOvarian Cancer | Fallopian Tube Carcinoma | Peritoneal CarcinomaItaly
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Canada, Spain, Norway, Belgium, Netherlands, United Kingdom, Portugal, Austria, Denmark, Ireland, Sweden, Italy, Argentina, Germany
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerItaly, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerSpain, Belgium, France, Netherlands, Austria, United Kingdom, Italy, South Africa, Portugal, Ireland
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerKorea, Republic of, United States, Italy, Belgium, Australia, France, Austria, China, Denmark, Germany, Greece, Spain, Sweden, Japan, Russian Federation, Turkey, Norway, Brazil, Czechia, Finland, Poland, Israel
-
Seagen Inc.GenmabCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Denmark, Ireland, Italy
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenEuropean CommissionCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaGermany, Belgium, Italy, Austria, France
-
Novartis PharmaceuticalsCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Greece, Canada, Finland, Italy, Spain, United Kingdom, France, Denmark, South Africa, Australia, Poland
-
Bristol-Myers SquibbEisai Inc.RecruitingNeoplasms, OvarianAustralia, United States, Korea, Republic of, Chile, Belgium, Italy, Spain, Israel, Japan
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Austria, Belgium, Italy, Netherlands, Spain, Canada, Denmark, Germany, Korea, Republic of, Russian Federation, Hong Kong, Greece, Japan
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Spain, Netherlands, Australia, United Kingdom, Italy, Portugal, Austria
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
MEI Pharma, Inc.CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
-
AGO Study GroupCancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerSpain, France, Denmark, Belgium, Germany, Austria, China, Italy, Korea, Republic of, Norway, Sweden, United Kingdom
-
Corcept TherapeuticsGynecologic Oncology GroupActive, not recruitingFallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian NeoplasmUnited States, Argentina, Australia, Belgium, Brazil, Canada, France, Hungary, Israel, Italy, Korea, Republic of, Poland, Spain, United Kingdom
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
ImmunoGen, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
-
CanariaBio Inc.Gynecologic Oncology Group; Iqvia Pty LtdActive, not recruitingOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Peritoneal Carcinoma | Peritoneal Cancer | Fallopian Tube Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Ovarian Serous AdenocarcinomaKorea, Republic of, United States, Taiwan, Czechia, Argentina, Spain, Belgium, Brazil, Chile, Canada, Italy, Hungary, India, Mexico
-
AstraZenecaOptum, Inc.CompletedEpithelial Ovarian/Fallopian Tube/Primary Peritoneal CancerUnited States, Italy, Spain
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
Corcept TherapeuticsActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States, Belgium, Canada, Italy, Spain
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerPoland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
Merck Sharp & Dohme LLCActive, not recruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian CancerUnited States, Germany, Israel, Canada, China, Australia, Belgium, Brazil, Chile, Colombia, Denmark, Finland, France, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Russian Federation, Turkey and more
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenoid Cystic Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Endometrial Neoplasms | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder Carcinoma | HER2 Negative Breast Neoplasms | Hormone Receptor Positive Breast NeoplasmsUnited States, Spain, Canada, United Kingdom, Germany, Italy
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia